Printer Friendly

Protective Effect of Decursin Extracted from Angelica gigas in Male Infertility via Nrf2/HO-1 Signaling Pathway.

1. Introduction

Infertility, which can be explained as the failure of a couple in trying to conceive after one year of frequent, unprotected sexual intercourse, is a serious clinical issue that affects 13-15% of couples worldwide [1]. Male infertility is responsible for 60% of cases involving conceptive couples with pregnancy-related problems [2]. Sperm is produced by the highly complicated process of spermatogenesis, and partial or complete interruption of spermatogenesis ultimately leads to oligospermia or azoospermia.

Observation study on male infertility with oligozoospermia or azoospermia, in particular, suggests that some patients may have testicular heat exposure due to an intrinsic defect in scrotal thermoregulation, varicocele, or work hazard [3]. Several studies report that testicular hyperthermia above normal ranges causes impaired spermatogenesis due to heat-related oxidative stress on the seminiferous tubules [4, 5]. Moreover, nuclear factor erythroid 2-related factor 2 (Nrf2) plays a significant role in preventing the development of oxidative stress in spermatogenesis [6]. Yu et al. [7] also demonstrated a strong correlation between functional discrepancy in Nrf2 promoter gene and abnormal spermatogenesis in humans.

Decursin, a major active ingredient from Angelica gigas Nakai (Apiaceae), has been reported to inhibit the growth of various cancer cells through cell cycle arrest and apoptosis [8, 9]. In addition, a protective effect of decursin has been suggested against the neurotoxicity in animal cortical cells [10]. Even further, decursin plays a major role as free radical scavenger and activated the upregulation of heme oxygenase-1 (HO-1) expression through stimulation of Nrf2, conferring protection against oxidative damage in rat pheochromocytoma (PC12) cells [11].

We examined the effects of decursin extracted from Angelica gigas on antioxidant activity in vitro and in a cryptorchidism-induced infertility rat model. We hypothesized that decursin-induced HO-1 expression would protect against heat stress-induced degeneration of testicular germ cells and apoptosis.

2. Methods

2.1. Preparation of Angelica gigas Extract and Characterization of Decursin. The extract of Angelica gigas used in our study was produced using the following method: commercial Angelica gigas roots were extracted with 12,000 mL of 30% ethanol for 3 hours at 90-100[degrees]C. The extracts were filtered twice through a 50 [micro]m and a 1 [micro]m filter and concentrated in vacuo and then lyophilized. Decursin in the Angelica gigas extract was analyzed and quantified by high performance liquid chromatography (HPLC) using Waters 2695 Preparation Module HPLC system (Waters Corporation, MA, USA). Several peaks were obtained in the HPLC chromatogram by diode array detection (DAD) at 230 nm. The major peak was identified as decursin by comparison with the standard compound (Figure 1). As a result of this assay, decursin content was quantified as 37.6 [+ or -] 2.2 mg/g.

2.2. Cell Viability Test In Vitro. TM3 cells, an immature mouse Leydig cell line (Korean Cell Line Bank, Seoul, Korea), were cultured in Dulbecco's modified Eagle's medium (DMEM)/F-12 medium (GIBCO, Life Technologies Co., USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; GIBCO) at 37[degrees]C. Cells (75,000 cells/mL medium/well) were plated in 24-well cluster dishes, unless otherwise specified. They were seeded on 96-well plates in 10% FBS/DMEM/F-12 and breeded for 24 hours. They were pretreated with the Angelica gigas extract for two hours and treated with 40 uM hydrogen peroxide ([H.sub.2][O.sub.2]) for two hours to create oxidative cellular stress. Afterwards, alamarBlue (Invitrogen, USA) was added to the cells, and the intensity of the presented color was measured at 570 nm using ELISA Reader (Molecular Devices, USA) after incubating for 3 hours. Cell viability was calculated as previously described [12].

2.3. Animal Groups and Treatment Protocol. This study was investigated in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee in School of Medicine, The Catholic University of Korea (CUMC-2012-0168-01). Thirty-six 8-week-old male Sprague-Dawley rats were treated under an approved protocol. Unilateral cryptorchidism in rats was surgically induced as previously described [13]. Animals were anesthetized, and a midline abdominal incision was performed. The gubernaculum on the left side was cut to displace the testis into the abdomen, and the inguinal canal was closed. The contralateral testis was sham-operated to act as the paired control; the gubernaculum was cut and the inguinal canal reconstructed. Either distilled water (n = 18, control groups) or 400 mg/kg of Angelica gigas extract (n = 18, treatment groups) was administered orally for 4 weeks after unilateral cryptorchidism was induced. Angelica gigas extract was dissolved in distilled water and administrated orally once a day. After 1, 2, and 4 weeks, six rats from the control group and six rats from treatment group were sacrificed and blood samples were collected. The testes and epididymides were resected after anesthesia and measured.

2.4. Evaluation of Cauda Epididymal Sperm Count and Motility. Samples of spermatozoa were collected from the caudal region of epididymis by mincing it finely in normal saline containing 0.5% bovine serum albumin at 37[degrees]C and then were filtered. Sperm suspensions were analyzed as previously described [14]. The sperm count represents the number of sperms in 1 mL of the medium. Sperm motility is expressed as the percentage of sperm that showed any movement.

2.5. Measurement of Spermatogenic Cell Density. Testicular tissues procured were fixed, embedded in paraffin, stained with haematoxylin-eosin, and inspected under a light microscope at x400 magnification. Ten characteristic sites in seminiferous tubules were selected randomly and spermatogenic cell density was measured. It was calculated as the diameter of germinal cell layer divided by the width of the seminiferous tubule [15].

2.6. Measurement of Oxidative Stress. Oxidative stress was assessed by measuring the 8-hydroxy-2-deoxyguanosine (8-OHdG) content and superoxide dismutase (SOD) activity quantitatively. Total DNA was extracted from the testis using the DNeasy Blood & Tissue kit (Qiagen, Valencia, CA, USA). The level of 8-OHdG was measured with a DNA oxidation kit (Highly Sensitive 8-OHdG Check ELISA; Japan Institute for the Control of Aging, Fukuroi, Japan). After the final color was developed with the addition of 3,3',5,5'- tetramethylbenzidine, absorbance was measured at 450 nm. Tissue sample concentration was measured from a standard curve and corrected for DNA concentration. SOD activity (CuZnSOD and Mn SOD) in tissue was determined using SOD Assay Kit-WST (Dojindo) and the decrease in the rate of superoxide-mediated reduction of nitroblue tetrazolium monitored at 450 nm using a spectrophotometer.

2.7. Western Blot Analysis. Western blot was performed by the standard method. Equal amounts of proteins were fractionated by SDS-PAGE gel electrophoresis and electro-transferred to Immun-Blot PVDF membrane (0.2 [micro]M pore size, Bio-Rad). Membranes were blocked overnight at 4[degrees]C in Tris-buffered saline (TBS), 0.05% (v/v) Tween-20, 150 mM NaCl, and 5% (w/v) bovine serum albumin (BSA, Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by 2 hours of incubation with primary antibody diluted in the same buffer. Immunoblot analysis was carried out using anti-Nrf2 (1/250), anti-HO-1 (1/1000), anti-Bax (1/1000), and anti-Bcl-2 (1: 1000) polyclonal antibody (Abcam Co., UK). After washing with TBS-T (TBS, 0.1% Tween 20), the membrane was incubated with anti-rabbit IgG AP-linked secondary antibody and then washed with the same buffer. The immunoblotted membrane was developed with BCIP/NBT color-developing solution. The blots in the samples were quantified by densitometry analysis using PDQuest software (Version 7.0, Bio-Rad, Hercules, CA, USA).

2.8. Quantitative Real-Time PCR. The frozen testes were homogenized with TRIzol reagent (Invitrogen, Carlsbad, CA, US) to extract mRNA and cDNA synthesis was performed using the SuperScript 3 First-Strand kit (Invitrogen, Carlsbad, CA, US) according to the manufacturer's information. Gene-specific primers were determined based on the corresponding mRNA sequences with Primer Version 5.0 (Table 1). PCR amplification of cDNA was performed in a real-time PCR machine step on plus (Applied Biosystems) with SYBR Green PCR Master Mix (Invitrogen) as indicated: 2 minutes at 50[degrees]C for dUTP activation and 10 minutes at 95[degrees]C for initial denaturation of cDNA followed by 40 cycles, each consisting of 15 s of denaturation at 95[degrees]C and 60 s at 60[degrees]C for primer annealing and chain extension.

2.9. Statistical Analysis. Statistical analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, USA). The data was expressed as mean [+ or -] standard deviation. Statistical significance was analyzed by ANOVA test and p < 0.05 was considered to be significant.

3. Results

3.1. Protective Effect against Oxidative Stress in TM3 Cells. To evaluate whether Angelica gigas extract could protect TM3 cells against [H.sub.2][O.sub.2]-induced damage, alamarBlue assay was performed. Incubation with [H.sub.2][O.sub.2] significantly decreased cell viability by 40% compared to untreated cells. Increased cell viability was found in a dose-dependent manner (Figure 2). The viabilities were increased to 140% and 165% by treatment with Angelica gigas extract concentrations of 10 [micro]g/mL and 50 [micro]g/mL, respectively.

3.2. Body and Testes Weights. There was no significant difference in contralateral testicular weights for four weeks. Upon cryptorchidism induction in the first week, there were also no significant differences in left testicular weights between the control group and the treatment group. However, the mean weight of the left testes from the treatment group was significantly larger compared with the control group on the second and fourth weeks (p < 0.05). The mean weights of the left testes are listed in Table 2.

3.3. Sperm Counts and Motility. Mean sperm counts and the percentage of motile spermatozoa in the left epididymis are shown in Table 2. There were no significant differences between the control and treatment groups in the first week, but mean sperm counts and the percentage of motile spermatozoa from the control group were significantly lower than those in the treatment group by the second and fourth weeks (p < 0.05).

3.4. Spermatogenic Cell Density. Upon cryptorchidism induction in the first week, considerable spermatocytes lined up the germinal cell layer in the control and the treatment groups (Figure 3). On the other hand, the seminiferous tubule is shrunken and the germinal cell layers are decreased in the control group after 2 weeks. The germinal cell layer in the treatment group was thicker compared with that of the control group by the second and fourth weeks (Table 2, p < 0.05). There was no significant difference in contralateral testicular spermatogenic cell density.

3.5. Measurement of Oxidative Stress. Mean expression of oxidative stress markers in the left testes is shown in Figure 4. There were no significant differences in 8-OHdG and SOD expression between the two groups in the first week. A time-dependent increase in 8-OHdG and a decrease in SOD were examined in the control group, but oxidative stress was observed to be significantly lower in the treatment group at the same period of time (p < 0.05).

3.6. Expression of Nrf2 and HO-1. We found that significant increases of Nrf2 and HO-1 proteins were exhibited in the treatment group compared with the control group by the second and fourth weeks (Figure 5(a)). There were no significant differences in Nrf2 and HO-1 mRNA in the control group across time points, but mRNA transcript levels were significantly higher in the treatment group compared with the control group by the second and fourth weeks (Figure 5(b)). Moreover, the progressive increase in Nrf2 levels was firmly associated with an increase in HO-1 expression.

3.7. Apoptosis-Related Protein Expression. The expression of proapoptotic (Bax) and antiapoptotic (Bcl-2) proteins was investigated. Treatment with Angelica gigas extract significantly declined the level of Bax protein with a collateral increase in Bcl-2 protein compared with the control group over the whole period (Figure 6(a)). These changes decreased the Bax/Bcl-2 ratio, which is considered to be an index to evaluate apoptosis (Figure 6(b)).

4. Discussion

The main findings of our study were as follows. The treatment with Angelica gigas extract (1) protected TM3 cells against [H.sub.2][O.sub.2]-induced oxidative stress in a dose-dependent manner, (2) improved the mean weight of the cryptorchid testis, (3) maintained sperm counts, motility, and spermatogenic cell density, (4) decreased levels of 8-OHdG and increased levels of SOD, demonstrating its antioxidant effect, (5) significantly increased Nrf2 and HO-1, and (6) significantly decreased apoptosis.

We evaluated the protective effect of Angelica gigas extract against [H.sub.2][O.sub.2]-induced oxidative stress in TM3 cells. In addition, we demonstrated that the mean weight of the cryptorchid testis in the control group was significantly decreased compared with that of the treatment group by the second and fourth weeks. Most mammal testes are more sensitive to heat than other organs, and scrotal temperature is lower than core body temperature [16, 17]. Elevated intratesticular temperature induces oxidative stress, resulting in apoptosis and impairment of spermatogenesis [18, 19]. It is correlated with a decrease in cellular antioxidant defenses or an increase in the production of reactive oxygen species (ROS) [20]. Several studies demonstrated that increased ROS impaired the physiological processes such as capacitation, hyperactivation, acrosome reactions, and signaling processes to provide appropriate fertilization [21]. Thus, antioxidant supplement may help improve the imbalance of an excessive ROS and restore sperm parameters.

Oral supplements and herbal medicines have been proposed to recover male factor infertility [22]. These supplements were reported to improve sperm quality, and their antioxidants are thought to decrease ROS in oligoasthenospermia patients [23-26]. We found that treatment with Angelica gigas extract decreases oxidative stress in cryptorchidism-induced rats and posit that the curative effects may contribute to suppression of ROS production. In addition, we examined the detailed mechanism of the antioxidant activity in Angelica gigas extract.

HO-1 is a stress-responsive protein shortly activated by variable noxious stimuli as well as oxidative stress. HO-1 has been known as the cytoprotective effect resistant to oxidative stress [27]. The Nrf2 antioxidant system also has been recognized as an important therapeutic target against oxidative stress, producing expression of cytoprotective enzymes and related proteins [28]. Previous studies have reported that oxdative stress resulted in lower epididymal sperm motility in Nrf2 knockout mice [6]. Nrf2 is released and transmits the stress signal to the nucleus for activation of a specific set of genes encoding phase II antioxidant enzymes as well as stress responsive proteins such as HO-1 [29].

Li et al. [30] studied about the oxidative damage on male reproductive organ. The whole body heat stress upregulated Nrf2 expression for about a week, but the significant increased oxidative stress was identified thereafter. Several supplements (e.g., sulforaphane, curcumin, and caffeic acid phenethyl ester) activate the Nrf2 antioxidant response element (ARE) system [31, 32]. Li et al. [11] reported that decursin treatment leads to the upregulation of Nrf2/HO-1 expression in PC12 cells. Decursin may have the possibilities to prevent chemotherapy-induced cytotoxicity via the activation of antioxidant enzyme. We found that decursin extracted from Angelica gigas increased Nrf2 and HO-1 in the cryptorchid testis. Moreover, a prevention of decrease in SOD was observed in the treatment group. Therefore, our results suggest that antioxidant defense is reinforced by decursin via activation of Nrf2 and upregulation of antioxidant enzyme activity.

The Bcl-2 family and related proteins are key regulators of apoptosis [33]. They can be classified into two groups: Bcl-2, an antiapoptotic protein, and Bax, a proapoptotic protein [34]. Knudson et al. [35] demonstrated that the Bcl-2 family mainly plays a role during spermatogenesis in Bax-deficient mice. Several studies have reported the importance of the Bcl-2 family in heat-induced oxidative stress on male reproductive function [36, 37]. They suggested the possible involvement of Bcl-2 and Bax in the germ cell apoptosis. We also investigated the germ cell apoptosis induced by cryptorchidism and the antiapoptotic effect of decursin extracted from Angelica gigas.

We examined the role of decursin extracted from Angelica gigas as a supplemental agent to prevent heat-induced oxidative stress in cryptorchidism. Our limitation is that the more accurate infertility model due to oxidative stress is needed. More defense mechanisms such as Nrf2 and related antioxidative enzyme are required if oxidative stress causes impaired semen parameters, DNA damage, and apoptosis. Antioxidant supplementation as well as lifestyle change like no smoking or balanced diet can be helpful for the natural balance between ROS and antioxidant. Therefore our study may support appropriate evidence for the use of a new complementary and alternative medicine for treating male infertility. In addition, future work should investigate a detailed mechanism of decursin with or without Nrf2 related enzyme activity.

The present study suggests that decursin extracted from Angelica gigas is a supplemental agent that can reduce oxidative stress by Nrf2-mediated upregulation of HO-1 and may improve cryptorchidism-induced infertility.

http://dx.doi.org/10.1155/2016/5901098

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant no. HI15C0099). This study was supported by Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea.

References

[1] J. P. Jarow, I. D. Sharlip, A. M. Belker et al., "Best practice policies for male infertility," The Journal of Urology, vol. 167, no. 5, pp. 2138-2144, 2002.

[2] P. Thonneau, S. Marchand, A. Tallec et al., "Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989)," Human Reproduction, vol. 6, no. 6, pp. 811-816, 1991.

[3] R. Dada, N. P. Gupta, and K. Kucheria, "Spermatogenic arrest in men with testicular hyperthermia," Teratog Carcinog Mutagen, supplement 1, pp. 235-243, 2003.

[4] A. Kumagai, H. Kodama, J. Kumagai et al., "Xanthine oxidase inhibitors suppress testicular germ cell apoptosis induced by experimental cryptorchidism," Molecular Human Reproduction, vol. 8, no. 2, pp. 118-123, 2002.

[5] R. M. Vigueras-Villasenor, I. Ojeda, O. Gutierrez-Perez et al., "Protective effect of a-tocopherol on damage to rat testes by experimental cryptorchidism," International Journal of Experimental Pathology, vol. 92, no. 2, pp. 131-139, 2011.

[6] B. N. Nakamura, G. Lawson, J. Y. Chan et al., "Knockout of the transcription factor NRF2 disrupts spermatogenesis in an age-dependent manner," Free Radical Biology and Medicine, vol. 49, no. 9, pp. 1368-1379, 2010.

[7] B. Yu, H. Lin, L. Yang et al., "Genetic variation in the Nrf2 promoter associates with defective spermatogenesis in humans," Journal of Molecular Medicine, vol. 90, no. 11, pp. 1333-1342, 2012.

[8] J. Guo, C. Jiang, Z. Wang et al., "A novel class of pyranocoumarin anti-androgen receptor signaling compounds," Molecular Cancer Therapeutics, vol. 6, no. 3, pp. 907-917, 2007.

[9] H. J. Lee, H. J. Lee, E. O. Lee et al., "In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin," The American Journal of Chinese Medicine, vol. 37, no. 1, pp. 127-142, 2009.

[10] S. Y. Kang and Y. C. Kim, "Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity," Journal of Pharmacy and Pharmacology, vol. 59, no. 6, pp. 863-870, 2007.

[11] L. Li, J.-K. Du, L.-Y. Zou, T. Wu, Y.-W. Lee, and Y.-H. Kim, "Decursin isolated from angelica gigas Nakai rescues PC12 cells from amyloid [beta]-protein-induced neurotoxicity through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of MAPK," Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 467245, 14 pages, 2013.

[12] H. J. Lee, J.-H. Bach, H.-S. Chae et al., "Mitogen-activated protein kinase/extracellular signal-regulated kinase attenuates 3-hydroxykynurenine-induced neuronal cell death," Journal of Neurochemistry, vol. 88, no. 3, pp. 647-656, 2004.

[13] W. J. Bae, U. S. Ha, K. S. Kim et al., "Effects of KH-204 on the expression of heat shock protein 70 and germ cell apoptosis in infertility rat models," BMC Complementary and Alternative Medicine, vol. 14, article 367, 2014.

[14] K. W. Ko, J. Y. Chae, S. W. Kim et al., "The effect of the partial obstruction site of the renal vein on testis and kidney in rats: is the traditional animal model suitable for varicocele research?" Korean Journal of Urology, vol. 51, no. 8, pp. 565-571, 2010.

[15] G. Turk, M. Sonmez, M. Aydin et al., "Effects of pomegranate juice consumption on sperm quality, spermatogenic cell density, antioxidant activity and testosterone level in male rats," Clinical Nutrition, vol. 27, no. 2, pp. 289-296, 2008.

[16] B. P. Setchell, "The Parkes lecture. Heat and the testis," Journal of Reproduction and Fertility, vol. 114, no. 2, pp. 179-194, 1998.

[17] P. J. Hansen, "Effects of heat stress on mammalian reproduction," Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 364, no. 1534, pp. 3341-3350, 2009.

[18] C. Paul, S. Teng, and P. T. K. Saunders, "A single, mild, transient scrotal heat stress causes hypoxia and oxidative stress in mouse testes, which induces germ cell death," Biology of Reproduction, vol. 80, no. 5, pp. 913-919, 2009.

[19] K. Shiraishi, H. Takihara, and H. Matsuyama, "Elevated scrotal temperature, but not varicocele grade, reflects testicular oxidative stress-mediated apoptosis," World Journal of Urology, vol. 28, no. 3, pp. 359-364, 2010.

[20] R. J. Aitken and S. D. Roman, "Antioxidant systems and oxidative stress in the testes," Oxidative Medicine and Cellular Longevity, vol. 1, no. 1, pp. 15-24, 2008.

[21] A. Agarwal, G. Virk, C. Ong, and S. S. du Plessis, "Effect of oxidative stress on male reproduction," The World Journal of Men's Health, vol. 32, no. 1, pp. 1-17, 2014.

[22] N. A. Clark, M. Will, M. B. Moravek, and S. Fisseha, "A systematic review of the evidence for complementary and alternative medicine in infertility," International Journal of Gynecology and Obstetrics, vol. 122, no. 3, pp. 202-206, 2013.

[23] A. Agarwal and L. H. Sekhon, "The role of antioxidant therapy in the treatment of male infertility," Human Fertility, vol. 13, no. 4, pp. 217-225, 2010.

[24] E. Greco, M. Iacobelli, L. Rienzi, F. Ubaldi, S. Ferrero, and J. Tesarik, "Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment," Journal of Andrology, vol. 26, no. 3, pp. 349-353, 2005.

[25] A. E. Omu, M. K. Al-Azemi, E. O. Kehinde, J. T. Anim, M. A. Oriowo, and T. C. Mathew, "Indications of the mechanisms involved in improved sperm parameters by zinc therapy," Medical Principles and Practice, vol. 17, no. 2, pp. 108-116, 2008.

[26] M. R. Safarinejad, "Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men," Journal of Urology, vol. 182, no. 1, pp. 237-248, 2009.

[27] L. E. Otterbein and A. M. K. Choi, "Heme oxygenase: colors of defense against cellular stress," American Journal of Physiology--Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1029-L1037, 2000.

[28] T. Ohta, K. Iijima, M. Miyamoto et al., "Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth," Cancer Research, vol. 68, no. 5, pp. 1303-1309, 2008.

[29] K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, T. O'Connor, and M. Yamamoto, "Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles," Genes to Cells, vol. 8, no. 4, pp. 379-391, 2003.

[30] Y. Li, Y. Huang, Y. Piao et al., "Protective effects of nuclear factor erythroid 2-related factor 2 on whole body heat stress-induced oxidative damage in the mouse testis," Reproductive Biology and Endocrinology, vol. 11, article 23, 2013.

[31] C. Chen and A.-N. T. Kong, "Dietary chemopreventive compounds and ARE/EpRE signaling," Free Radical Biology and Medicine, vol. 36, no. 12, pp. 1505-1516, 2004.

[32] Y. Morimitsu, Y. Nakagawa, K. Hayashi et al., "A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway," The Journal of Biological Chemistry, vol. 277, no. 5, pp. 3456-3463, 2002.

[33] J. M. Adams and S. Cory, "The Bcl-2 protein family: arbiters of cell survival," Science, vol. 281, no. 5381, pp. 1322-1326, 1998.

[34] Y. Akao, Y. Otsuki, S. Kataoka, Y. Ito, and Y. Tsujimoto, "Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes," Cancer Research, vol. 54, no. 9, pp. 2468-2471, 1994.

[35] C. M. Knudson, K. S. K. Tung, W. G. Tourtellotte, G. A. J. Brown, and S. J. Korsmeyer, "Bax-deficient mice with lymphoid hyperplasia and male germ cell death," Science, vol. 270, no. 5233, pp. 96-99, 1995.

[36] C. M. Yamamoto, A. P. Sinha Hikim, P. N. Huynh et al., "Redistribution of Bax is an early step in an apoptotic pathway leading to germ cell death in rats, triggered by mild testicular hyperthermia," Biology of Reproduction, vol. 63, no. 6, pp. 1683-1690, 2000.

[37] Z.-H. Zhang, X. Jin, X.-S. Zhang et al., "Bcl-2 and Bax are involved in experimental cryptorchidism-induced testicular germ cell apoptosis in rhesus monkey," Contraception, vol. 68, no. 4, pp. 297-301, 2003.

Woong Jin Bae, (1,2) U. Syn Ha, (2) Jin Bong Choi, (2) Kang Sup Kim, (2) Su Jin Kim, (2) Hyuk Jin Cho, (2) Sung Hoo Hong, (2) Ji Youl Lee, (2) Zhiping Wang, (3) Sung Yeoun Hwang, (4) and Sae Woong Kim (1,2)

(1) Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea

(2) Department of Urology, College of Medicine, The Catholic University of Korea, Banpo-daero 222, Seocho-gu, Seoul 137-701, Republic of Korea

(3) Department of Urology, Second Hospital of Lanzhou University, Lanzhou, China

(4) Korea Bio Medical Science Institute, Seoul, Republic of Korea

Correspondence should be addressed to Sae Woong Kim; ksw1227@catholic.ac.kr

Received 21 September 2015; Revised 17 November 2015; Accepted 6 December 2015

Academic Editor: Sergio Di Meo

Caption: Figure 1: HPLC chromatogram of the extract of Angelica gigas (a) and the standard solution (b). The peak with the arrow indicates decursin in standard compounds. A corresponding peak was seen in the extract HPLC chromatogram.

Caption: Figure 2: Protective effects of Angelica gigas extract against [H.sub.2][O.sub.2]. The cells were pretreated with the extract of Angelica gigas 2 hours before [H.sub.2][O.sub.2] treatment. * P < 0.05 as compared with the control group.

Caption: Figure 3: Time-dependent histopathological findings of left testis (haematoxylin and eosin stain). Scale bars shown in each figure represent 100 [micro]m. AG, the extract of Angelica gigas treatment.

Caption: Figure 4: Comparison of the expression levels of SOD (a) and 8-OHdG (b). AG, the extract of Angelica gigas treatment. * P < 0.05 as compared with the control group at the same period of time.

Caption: Figure 5: Effect of Angelica gigas extract on protein expression (a) and mRNA expression (b) of Nrf2-regulated genes. AG, the extract of Angelica gigas treatment; HO-1, heme oxygenase-1; Nrf2, nuclear factor erythroid 2-related factor 2. * P < 0.05 as compared with the control group at the same period of time.

Caption: Figure 6: Comparison of the expression levels of Bax and Bcl-2 expression in the testicular tissue. (a) Western blot analysis of Bax and Bcl-2. (b) Densitometric analysis of Bax, Bcl-2, and Bax/Bcl-2 ratio relative to beta- actin. AG, the extract of Angelica gigas treatment. * P < 0.05 as compared with the control group at the same period of time.
Table 1: Primers used for real-time PCR.

Gene                               GenBank
                               accession number

Beta-actin (ACTB)                  NM007393

Nuclear factor erythroid           NM010902
2-related factor 2

Heme oxygenase-1                   NM010442

Gene                                 Sequence
                               (5' [right arrow] 3')

Beta-actin (ACTB)              F: CTGTCCCTGTATGCCTCTG
                               R: ATGTCACGCACGATTTCC

Nuclear factor erythroid       F: CAGTGCTCCTATGCGTGAA
2-related factor 2             R: GCGGCTTGAATGTTTGTC

Heme oxygenase-1               F: ACAGATGGCGTCACTTCG
                               R: TGAGGACCCACTGGAGGA

Gene                          Length of DNA
                               product (bp)

Beta-actin (ACTB)                   218

Nuclear factor erythroid            109
2-related factor 2

Heme oxygenase-1
                                    128

Table 2: Comparisons of parameters of the cryptorchid
testicular health.

                            Left testicular
                               weight (g)

1st week     Control      1.526 [+ or -] 0.225
                AG        1.612 [+ or -] 0.033

2nd week     Control      1.232 [+ or -] 0.165
                AG        1.515 [+ or -] 0.367 *

4th week     Control      0.858 [+ or -] 0.285
                AG        1.433 [+ or -] 0.634 *

                             Sperm count
                         (x[10.sup.6]/g cauda)

1st week     Control      350.2 [+ or -] 10.9
                AG        360.6 [+ or -] 14.0

2nd week     Control      240.2 [+ or -] 13.6
                AG        300.8 [+ or -] 12.5 *

4th week     Control       75.2 [+ or -] 18.2
                AG        310.5 [+ or -] 14.7 *

                            % of motile
                             spermatozoa

1st week     Control      20.7 [+ or -] 3.3
                AG        22.5 [+ or -] 5.2

2nd week     Control       7.6 [+ or -] 2.3
                AG        14.5 [+ or -] 2.7 *

4th week     Control       5.7 [+ or -] 3.1
                AG        13.2 [+ or -] 8.2 *

                             Spermatogenic
                              cell density

1st week     Control      0.343 [+ or -] 0.016
                AG        0.305 [+ or -] 0.031

2nd week     Control      0.275 [+ or -] 0.043
                AG        0.314 [+ or -] 0.074 *

4th week     Control      0.154 [+ or -] 0.028
                AG        0.269 [+ or -] 0.052 *

Data show the mean [+ or -] SD AG, the extract of Angelica
gigas treatment.

* p < 0.05 as compared with the control group at the same
period of time.
COPYRIGHT 2016 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Bae, Woong Jin; Ha, U. Syn; Choi, Jin Bong; Kim, Kang Sup; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung Ho
Publication:Oxidative Medicine and Cellular Longevity
Date:Jan 1, 2016
Words:4825
Previous Article:Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress.
Next Article:Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters